The Journal of Urology
Volume 181, Issue 3 , Pages 1082-1090 , March 2009

Laterality Alone Should Not Drive Selection of Candidates for Hemi-Ablative Focal Therapy

  • Basir Tareen
    • ,
  • Guilherme Godoy
    • ,
  • Alex Sankin
    • ,
  • Steve Temkin
    • ,
  • Herbert Lepor

      Affiliations

    • Financial interest and/or other relationship with Med Reviews and US HIFU.
    • ,
  • Samir S. Taneja

      Affiliations

    • Corresponding Author InformationCorrespondence: NYU Urology Associates, 150 East 32nd St., Suite 200, New York, New York 10016 (telephone: 646-825-6321; FAX: 646-825-6399)
    • Financial interest and/or other relationship with GTX, Envisioneering and GlaxoSmithKline.

Received 23 June 2008

References 

  1. Carroll PR. Early stage prostate cancer—do we have a problem with over-detection, overtreatment or both?. J Urol. 2005;173:1061
  2. Harlan SR, Cooperberg MR, Elkin EP, Lubeck DP, Meng MV, Mehta SS, et al. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol. 2003;170:1804
  3. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, et al. The contemporary management of prostate cancer in the United States: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a national disease registry. J Urol. 2004;171:1393
  4. Mouraviev V, Mayes JM, Madden JF, Sun L, Polascik TJ. Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy. Technol Cancer Res Treat. 2007;6:91
  5. Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, et al. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy—results from the SEARCH database. J Urol. 2007;178:1249
  6. Connolly SS, O'Malley KJ, O'Brien A, Kelly DG, Mulvin DW, Quinlan DM. Can prostate biopsies predict suitability for nerve-sparing radical prostatectomy?. Scand J Urol Nephrol. 2004;38:216
  7. Sanwick JM, Dalkin BL, Nagle RB. Accuracy of prostate needle biopsy in predicting extracapsular tumor extension at radical retropubic prostatectomy: application in selecting patients for nerve-sparing surgery. Urology. 1998;52:814
  8. Bostwick DG, Foster CS. Pathology of the Prostate. Philadelphia: WB Saunders Co; 1998;p 72
  9. Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J. “Male lumpectomy”: focal therapy for prostate cancer using cryoablation. Urology. 2007;70:16
  10. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007;69:1117
  11. Cheng L, Jones TD, Pan CX, Barbarin A, Eble JN, Koch MO. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol. 2005;18:1022
  12. Noguchi M, Stamey TA, McNeal JE, Nolley R. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol. 2003;170:459
  13. Wise AM, Stamey TA, McNeal JE, Clayton JL. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002;60:264
  14. Ohori M, Eastham JA, Koh H, Kurolwa K, Slawin K, Wheeler TM, et al. Is focal therapy reasonable with early stage prostate cancer—an analysis of radical prostatectomy specimens. J Urol. 2006;175(suppl.):507;abstract 1574
  15. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer. 2005;103:1625
  16. Mouraviev V, Sun L, Madden JF, Mayes JM, Moul JW, Polascik TJ. Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy. Urology. 2007;70:1141
  17. Furuno T, Demura T, Kaneta T, Gotoda H, Muraoka S, Sato T, et al. Difference of cancer core distribution between first and repeat biopsy in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate. 2004;58:76
  18. Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer. 2007;110:906
  19. Tareen U, Sankin A, Temkin S, Lepor H, Taneja SS. Do biopsy characteristics predict unilateral prostate cancer on radical prostatectomy?. Eur Urol. 2008;7(suppl.):252
  20. Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007;177:540

 Study received institutional review board approval.

 Supported by the Bruce and Cynthia Sherman Fellowship in Urologic Oncology (BT, GG).

PII: S0022-5347(08)03003-6

doi: 10.1016/j.juro.2008.10.155

The Journal of Urology
Volume 181, Issue 3 , Pages 1082-1090 , March 2009

Article Tools

* Image Usage & Resolution